Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 1/20 | 0.44 |
| ▸ | NMUR2 | Q9GZQ4 | 4/20 | 0.43 |
| ▸ | NMUR1 | Q9HB89 | 4/20 | 0.43 |
| ▸ | PLK1 | P53350 | 1/20 | 0.43 |
| ▸ | RAMP3 | O60896 | 7/20 | 0.41 |
| ▸ | CALCR | P30988 | 7/20 | 0.41 |
| ▸ | NAA50 | Q9GZZ1 | 1/20 | 0.40 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25504123 | 0.92 | APLNR (0.47) | APLNRNMUR2NMUR1RAMP3CALCR | |
| SCHEMBL25475431 | 0.91 | APLNR (0.48) | APLNRNMUR2NMUR1RAMP3CALCR | |
| SCHEMBL25475911 | 0.90 | APLNR (0.50) | APLNRNMUR2NMUR1RAMP3CALCR | |
| SCHEMBL29569552 | 0.86 | NMUR2 (0.47) | APLNRNMUR2NMUR1RAMP3CALCR | |
| SCHEMBL29889179 | 0.86 | NMUR2 (0.47) | NMUR2NMUR1RAMP3CALCROPRM1 | |
| SCHEMBL29568732 | 0.85 | NMUR2 (0.47) | APLNRNMUR2NMUR1RAMP3CALCR | |
| SCHEMBL31367020 | 0.84 | NMUR2 (0.45) | APLNRNMUR2NMUR1PLK1RAMP3 | |
| SCHEMBL29570031 | 0.84 | NMUR2 (0.50) | NMUR2NMUR1RAMP3CALCRCXCR4 | |
| SCHEMBL29568813 | 0.84 | APLNR (0.48) | APLNRNMUR2NMUR1PLK1RAMP3 | |
| SCHEMBL29568619 | 0.84 | APLNR (0.48) | APLNRNMUR2NMUR1PLK1RAMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023078464-A1 | EPSILON-POLY-L-LYSINE-BASED DRUG CONJUGATE, INTERMEDIATE THEREOF, AND APPLICATION THEREOF | 上海弼领生物技术有限公司 | 2023-05-11 | — | — | WO | disclosed |